Corgenix
This article was originally published in The Gray Sheet
Executive Summary
Denver company receives 510(k) clearance for IgG and IgM anti-Prothrombin antibody test kits for detection of key markers in the blood of patients at risk for thrombosis. Tests are part of the firm's ELISA line of diagnostic assays for antiphospholipid antibody detection. Corgenix notes that it is first to receive FDA clearance for anti-Prothrombin tests